Meeting of the Strategic Advisory Group of Experts on Immunization, November 2010 ? summary, conclusions and recommendations (WHO, extract, edited)
[Source: World Health Organization, full PDF document (LINK). Extract, edited.]...
16 results in 0.0623 seconds.
-
Giuseppe started a topic Meeting of the Strategic Advisory Group of Experts on Immunization, November 2010 ? summary, conclusions and recommendations (WHO, extract, edited)in WHO (OMS)Meeting of the Strategic Advisory Group of Experts on Immunization, November 2010 ? summary, conclusions and recommendations (WHO, extract, edited)
-
Giuseppe started a topic Vaccine. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03(A)-adjuvant: Preliminary report of an observer-blind, randomized trial.in VaccinesVaccine. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03(A)-adjuvant: Preliminary report of an observer-blind, randomized trial.
Vaccine. 2009 Dec 21. [Epub ahead of print]
Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03(A)-adjuvant: Preliminary report of an observer-blind, randomized trial.
... -
Giuseppe started a topic Lancet. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.in VaccinesLancet. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.
Lancet. 2009 Dec 15. [Epub ahead of print]
Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.
Liang XF, Wang HQ, Wang JZ, Fang HH,... -
Giuseppe started a topic Lancet. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.in VaccinesLancet. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.
Lancet. 2009 Dec 15. [Epub ahead of print]
Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.
Plennevaux E, Sheldon E, Blatter M,... -
Giuseppe started a topic Vaccine development: experience from H5N1 to pandemic (H1N1) 2009 (WHO, presentation)in WHO (OMS)Vaccine development: experience from H5N1 to pandemic (H1N1) 2009 (WHO, presentation)
Source Full PDF Document: Marie-Paule Kieny - Vaccine development: experience from H5N1 to pandemic (H1N1) 2009 [pdf 1.26Mb] -
Giuseppe started a topic J Infect Dis. Evidence of Bias in Studies of Influenza Vaccine Effectiveness in Elderly Patients.in VaccinesJ Infect Dis. Evidence of Bias in Studies of Influenza Vaccine Effectiveness in Elderly Patients.
J Infect Dis. 2009 Dec 2. [Epub ahead of print]
Evidence of Bias in Studies of Influenza Vaccine Effectiveness in Elderly Patients.
Baxter R, Lee J, Fireman B. - Vaccine Study Center and 2Division of Research, Kaiser Permanente,... -
BMJ. Why don?t we have all the evidence on oseltamivir?
Why don't we have all the evidence on oseltamivir? -- Godlee and Clarke 339: b5351 (BMJ, extract, edited)
[Source Full Free Document: LINK. EDITED.]...
Published 8 December 2009, doi:10.1136/bmj.b5351
Cite this as: BMJ 2009;339:b5351 -
BMJ. What can we learn from observational studies of oseltamivir to treat influenza in healthy adults?
-
BMJ. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis -- Jefferson et al. 339: b5106 (BMJ, abstract, edited)
Published 8 December 2009, doi:10.1136/bmj.b5106...
Cite this as: -
Giuseppe started a topic Wkly Epidemiol Rec. Pandemic influenza A (H1N1) 2009 virus vaccine ? conclusions and recommendations from the October 2009 meeting of the immunization Strategic Advisory Group of Expertsin VaccinesWkly Epidemiol Rec. Pandemic influenza A (H1N1) 2009 virus vaccine ? conclusions and recommendations from the October 2009 meeting of the immunization Strategic Advisory Group of Experts
-
Giuseppe started a topic Euro Surveill. A simple mathematical approach to deciding the dosage of vaccine against pandemic H1N1 influenzain VaccinesEuro Surveill. A simple mathematical approach to deciding the dosage of vaccine against pandemic H1N1 influenza
A simple mathematical approach to deciding the dosage of vaccine against pandemic H1N1 influenza (Euro Surveill., edited)
Eurosurveillance, Volume 14, Issue 45, 12 November 2009
Rapid communications
A simple... -
Giuseppe started a topic Euro Surveill. Pandemic influenza A(H1N1) 2009 vaccines in the European Unionin VaccinesEuro Surveill. Pandemic influenza A(H1N1) 2009 vaccines in the European Union
Euro Surveill. Pandemic influenza A(H1N1) 2009 vaccines in the European Union (edited)
Eurosurveillance, Volume 14, Issue 41, 15 October 2009...
Perspectives
Pandemic influenza A(H1N1) 2009 vaccines in the European Uni -
ECDC - Technical Document - Protocol for cohort database studies to measure influenza vaccine effectiveness in the European Union and European Economic Area Member States - 17 July 2009
[Table of contents below, full content at link]
Protocol for cohort database studies to measure influenza vaccine effectiveness in the European Union and European Economic Area Member States
<title>HTML clipboard</title><meta... -
ECDC - Technical Document - Protocol for case-control studies to measure influenza vaccine effectiveness in the European Union and European Economic Area Member States - 17 July 2009
[Table of contents below; full document at link]
Protocol for case-control studies to measure influenza vaccine effectiveness in the European Union and European Economic Area Member States
<title>HTML clipboard</title><meta... -
Giuseppe started a topic Vaccine. On the use of hemagglutination-inhibition for influenza surveillance: Surveillance data are predictive of influenza vaccine effectiveness.in VaccinesVaccine. On the use of hemagglutination-inhibition for influenza surveillance: Surveillance data are predictive of influenza vaccine effectiveness.
Vaccine. 2009 Apr 21;27(18):2447-52. Epub 2009 Feb 24.
On the use of hemagglutination-inhibition for influenza surveillance: Surveillance data are predictive of influenza vaccine effectiveness.
Ndifon W, Dushoff J, Levin SA....